GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Cyclically Adjusted Book per Share

KPC Pharmaceuticals (SHSE:600422) Cyclically Adjusted Book per Share : ¥5.87 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

KPC Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was ¥7.062. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥5.87 for the trailing ten years ended in Mar. 2025.

During the past 12 months, KPC Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 6.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of KPC Pharmaceuticals was 19.30% per year. The lowest was 9.20% per year. And the median was 14.90% per year.

As of today (2025-06-02), KPC Pharmaceuticals's current stock price is ¥15.94. KPC Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥5.87. KPC Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 2.72.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of KPC Pharmaceuticals was 16.69. The lowest was 1.97. And the median was 3.31.


KPC Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for KPC Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Cyclically Adjusted Book per Share Chart

KPC Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.82 4.34 4.90 5.37 5.76

KPC Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.49 5.57 5.72 5.76 5.87

Competitive Comparison of KPC Pharmaceuticals's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

KPC Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, KPC Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=7.062/115.1156*115.1156
=7.062

Current CPI (Mar. 2025) = 115.1156.

KPC Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.051 99.500 3.530
201509 2.709 100.500 3.103
201512 4.199 100.600 4.805
201603 4.308 102.200 4.852
201606 4.287 101.400 4.867
201609 4.413 102.400 4.961
201612 4.511 102.600 5.061
201703 4.632 103.200 5.167
201706 4.611 103.100 5.148
201709 4.586 104.100 5.071
201712 4.648 104.500 5.120
201803 4.771 105.300 5.216
201806 4.700 104.900 5.158
201809 4.906 106.600 5.298
201812 5.011 106.500 5.416
201903 5.137 107.700 5.491
201906 5.230 107.700 5.590
201909 5.383 109.800 5.644
201912 5.514 111.200 5.708
202003 5.647 112.300 5.789
202006 5.546 110.400 5.783
202009 5.733 111.700 5.908
202012 5.870 111.500 6.060
202103 6.127 112.662 6.260
202106 6.079 111.769 6.261
202109 6.215 112.215 6.376
202112 6.308 113.108 6.420
202203 6.460 114.335 6.504
202206 6.347 114.558 6.378
202209 6.555 115.339 6.542
202212 6.572 115.116 6.572
202303 6.745 115.116 6.745
202306 6.709 114.558 6.742
202309 6.922 115.339 6.909
202312 8.658 114.781 8.683
202403 7.154 115.227 7.147
202406 7.100 114.781 7.121
202409 7.309 115.785 7.267
202412 6.940 114.893 6.953
202503 7.062 115.116 7.062

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


KPC Pharmaceuticals  (SHSE:600422) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

KPC Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.94/5.87
=2.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of KPC Pharmaceuticals was 16.69. The lowest was 1.97. And the median was 3.31.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


KPC Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


KPC Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals Headlines

No Headlines